BioCentury
ARTICLE | Clinical News

Cephalosporin prodrug: ETRX said partner JNJ's Pharmaceutical R&D subsidiary started a Phase I trial of its cephalosporin prodrug

July 29, 2002 7:00 AM UTC

Essential Therapeutics Inc. (ETRX), Waltham, Mass. Johnson & Johnson (JNJ), New Brunswick, N.J. Product: Cephalosporin prodrug Business: Infectious diseases Therapeutic category: Bacterial infection ...